Retrospective study investigates prevalence of resistant bacteria in ICU patients, suggesting monitoring in COVID-19 cases.
Aim: Vancomycin-resistant enterococci (VRE) and carbapenem-resistant Gram-negative Bacilli (CRGNB) cause serious hospital-acquired infections. In our study, we aimed to investigate the prevalence and duration of colonization of these agents in patients with and without COVID-19.Material and Methods: Rectal swabs of all patients hospitalized in the Intensive Care Unit (ICU) between June 2019 and December 2022 were retrospectively examined for the presence of VRE and CRGNB.Results: Of 186 non-COVID-19 patients, VRE was detected in 37 (19.9%), and CR Klebsiella pneumoniae in one (0.5%), while no agent was found in 148 patients (79.6%). However, of 250 COVID-19 patients, VRE and CRGNB were detected together in 47 (18.8%), while VRE was positive in 32 (12.8%) and CRGNB was positive in 87 (34.8%) (p<0.05). In patients without COVID-19, VRE and CRGNB colonization times were determined as 10.5±2.11 std and 7 ± 0 std days, respectively. In COVID-19 patients, VRE colonization time was 17.05±3.50 std days and CRGNB colonization time was 13.72±3.01 days, and the time to negativity after colonization was determined as 12.26±1.52 days and 14.45±2.57 days, respectively. While the colonization time detected in COVID-19 patients was found to be significantly increased for VRE compared to those without COVID-19 patients (p=0.0002).Conclusion: The higher rate and longer duration time of VRE and CRGNB colonization generally in patients with COVID-19 compared to those without COVID-19 suggests that this patient group should be closely monitored for possible resistant infections.
No takes yet. Share an insight, caveat, or question.
Gezdirici et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: